In vitro binding of simian immunodeficiency virus matrix protein to the cytoplasmic domain of the envelope glycoprotein

Virology

Volumn 374, Issue 2, 2008, Pages 273-279

  Manrique, Julieta M ^a   Affranchino, José L ^a   González, Silvia A ^a  

^a UNIVERSIDAD DE BELGRANO   (Argentina)

Author keywords

Envelope glycoprotein cytoplasmic domain; Matrix protein; Simian immunodeficiency virus; Virus assembly

Indexed keywords

GAG PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ARTICLE; DISSOCIATION CONSTANT; FELINE IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS MUTATION; VIRUS PARTICLE;

ANIMALS; CELL LINE; CYTOPLASM; HUMANS; RECOMBINANT PROTEINS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 42649113079     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.01.015     Document Type: Article

References (39)

1. Bhattacharya J., Peters P.J., and Clapham P.R. Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J. Virol. 78 (2004) 5500-5506
2. Biorn A.C., Cocklin S., Madani N., Si Z., Ivanovic T., Samanen J., Van Ryk D.I., Pantophlet R., Burton D.R., Freire E., Sodroski J., and Chaiken I.M. Mode of action for linear peptide inhibitors of HIV-1 gp120 interactions. Biochemistry 43 (2004) 1928-1938
3. Braaten D., Franke E.K., and Luban J. Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses. J. Virol. 70 (1996) 4220-4227
4. Celma C.C.P., Manrique J.M., Affranchino J.L., Hunter E., and González S.A. Domains in the simian immunodeficiency virus gp41 cytoplasmic tail required for envelope incorporation into particles. Virology 283 (2001) 253-261
5. Celma C.C.P., Paladino M.G., González S.A., and Affranchino J.L. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions. Virology 366 (2007) 405-414
6. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 (1998) 681-684
7. Cosson P. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J. 15 (1996) 5783-5788
8. Chong S., Mersha F.B., Comb D.G., Scott M.E., Landry D., Vence L.M., Perler F.B., Benner J., Kucera R.B., Hirvonen C.A., Pelletier J.J., Paulus H., and Xu M.Q. Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. Gene 192 (1997) 271-281
9. Dorfman T., Mammano F., Haseltine W.A., and Göttlinger H.G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 69 (1994) 1689-1696
10. Egan M.A., Carruth L.M., Rowell J.F., Yu X., and Siliciano R.F. Human immunodeficiency virus type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 70 (1996) 6547-6556
11. Formosa T., Barry J., Alberts B.M., and Greenblatt J. Using protein affinity chromatography to probe structure of protein machines. Methods Enzymol. 208 (1991) 24-45
12. Freed E.O., and Martin M.A. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69 (1995) 1984-1989
13. Freed E.O., and Martin M.A. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70 (1996) 341-351
14. González S.A., and Affranchino J.L. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein. Virology 210 (1995) 501-507
15. González S.A., and Affranchino J.L. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor. Virology 240 (1998) 27-35
16. González S.A., Affranchino J.L., Gelderblom H.R., and Burny A. Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology 194 (1993) 548-556
17. González S.A., Burny A., and Affranchino J.L. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation. J. Virol. 70 (1996) 6384-6389
18. Henderson L.E., Bowers M.A., Sowder II R.C., Serabyn S.A., Johnson D.E., Bess Jr. J.W., Arthur L.O., Bryant D.K., and Fenselau C. Gag protein of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66 (1992) 1856-1865
19. Hill C.P., Worthylake D., Bancroft D.P., Christensen A.M., and Sundquist W.I. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl. Acad. Sci. USA 93 (1996) 3099-3104
20. Hoffman T.L., Canziani G., Jia L., Rucker J., and Doms R.W. A biosensor assay for studying ligand-membrane receptor interaction: binding of antibodies and HIV-1 Env to chemokine receptors. Proc. Natl. Acad. Sci. USA 97 (2000) 11215-11220
21. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5 (1994) 71-83
22. Ivey-Hoyle M., Culp J.S., Chaikin M.A., Hellmig B.D., Matthews T.J., Sweet R.W., and Rosenberg M. Envelope glycoproteins from biologically diverse isolates from immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA 88 (1991) 512-516
23. Gag. J. Virol. 75 (2001) 10537-10542
24. Kalia V., Sarkar S., Gupta P., and Montelaro R.C. Rational site-directed mutations of the LLP-1 and LLP-2 lentivirus lytic peptide domains in the intracytoplasmic tail of human immunodeficiency virus type 1 gp41 indicate common functions in cell-cell fusion but distinct roles in virion envelope incorporation. J. Virol. 77 (2003) 3634-3646
25. Krise J.P., Sincock P.M., Orsel J.G., and Pfeffer S.R. Quantitative analysis of TIP47-receptor cytoplasmic domain interactions: implications for endosome-to-trans Golgi network trafficking. J. Biol. Chem. 275 (2000) 25188-25193
26. Li J., Lord C.I., Haseltine W., Letvin N.L., and Sodroski J. Infection of cynomologus monkeys with a chimeric HIV-1/SIVmac virus that expresses the HIV-1 envelope glycoproteins. J. Acquir. Immune Defic. Syndr. 5 (1992) 639-646
27. Lopez-Vergès S., Camus G., Blot G., Beauvoir R., Benarous R., and Berlioz-Torrent C. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl. Acad. Sci. USA 103 (2006) 14947-14952
28. Manrique J.M., Celma C.C.P., Affranchino J.L., Hunter E., and González S.A. Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry. AIDS Res Hum. Retrovir. 17 (2001) 1615-1624
29. Manrique J.M., Celma C.C.P., Hunter E., Affranchino J.L., and González S.A. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N-terminus of the simian immunodeficiency virus matrix protein. J. Virol. 77 (2003) 10881-10888
30. Manrique M.L., Rauddi M.L., González S.A., and Affranchino J.L. Functional domains in the feline immunodeficiency virus nucleocapsid protein. Virology 327 (2004) 83-92
31. Mason Jr. P.B., and Lis J.T. Cooperative and competitive protein interactions at the Hsp70 promoter. J. Biol. Chem. 272 (1997) 33227-33233
32. Murakami T., and Freed E.O. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and α-helix 2 of the gp41 cytoplasmic tail. J. Virol. 74 (2000) 3548-3554
33. Murakami T., Ablan S., Freed E.O., and Tanaka Y. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity. J. Virol. 78 (2004) 1026-1031
34. Phizicky E.M., and Fields S. Protein-protein interactions: methods for detection and analysis. Microbiol. Rev. 59 (1995) 94-123
35. Preusser A., Briese L., Baur A.S., and Willbold D. Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. J. Virol. 75 (2001) 3960-3964
36. Rao Z., Belyaev A.S., Fry E., Roy P., Jones I.M., and Stuart D.I. Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378 (1995) 743-747
37. Gag in immature human immunodeficiency virus type 1 particles. J. Virol. 74 (2000) 9381-9387
38. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., and Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 78 (2004) 3429-3435
39. Yu X., Yuan X., Matsuda Z., Lee T.-H., and Essex M. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66 (1992) 4966-4971